Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia　― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―

Koutaro Yokote; Kiyoshi Niwa; Tomomi Hakoda; Fumiki Oh; Yoshitaka Kajimoto; Toshiki Fukui; Hyosung Kim; Yoshinori Noda; Torbjörn Lundström; Toshitaka Yajima

doi:10.1253/circj.cj-19-0358

Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia　― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―

Circulation Journal ◽

10.1253/circj.cj-19-0358 ◽

2020 ◽

Vol 84 (6) ◽

pp. 994-1003 ◽

Cited By ~ 1

Author(s):

Koutaro Yokote ◽

Kiyoshi Niwa ◽

Tomomi Hakoda ◽

Fumiki Oh ◽

Yoshitaka Kajimoto ◽

...

Keyword(s):

Fatty Acids ◽

Free Fatty Acids ◽

Japanese Patients ◽

Phase Iii ◽

Omega 3 ◽

Short Term ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

Allergology International ◽

10.1016/j.alit.2016.05.014 ◽

2017 ◽

Vol 66 (1) ◽

pp. 97-105 ◽

Cited By ~ 9

Author(s):

Kimihiro Okubo ◽

Minoru Gotoh ◽

Mikiya Asako ◽

Yasuyuki Nomura ◽

Michinori Togawa ◽

...

Keyword(s):

Allergic Rhinitis ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Perennial Allergic Rhinitis ◽

Double Blind ◽

Double Blind Placebo ◽

Parallel Group ◽

Phase Iii Study

Download Full-text

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Short-Acting β1-Adrenergic Receptor Blocker Landiolol Hydrochloride for Coronary Computed Tomography Angiography in Japanese Patients with Suspected Ischemic Cardiac Disease

Clinical Drug Investigation ◽

10.1007/s40261-013-0149-y ◽

2013 ◽

Vol 34 (1) ◽

pp. 53-62 ◽

Cited By ~ 5

Author(s):

Masaharu Hirano ◽

◽

Akira Yamashina ◽

Kazuhiro Hara ◽

Yuji Ikari ◽

...

Keyword(s):

Computed Tomography ◽

Cardiac Disease ◽

Adrenergic Receptor ◽

Coronary Computed Tomography Angiography ◽

Japanese Patients ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Landiolol Hydrochloride ◽

Phase Iii Study

Download Full-text

Omega-3 Fatty Acids as a Treatment for Pediatric Depression. A Phase III, 36 Weeks, Multi-Center, Double-Blind, Placebo-Controlled Randomized Superiority Study

Frontiers in Psychiatry ◽

10.3389/fpsyt.2019.00863 ◽

2019 ◽

Vol 10 ◽

Cited By ~ 2

Author(s):

Isabelle Häberling ◽

Gregor Berger ◽

Klaus Schmeck ◽

Ulrike Held ◽

Susanne Walitza

Keyword(s):

Fatty Acids ◽

Phase Iii ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Pediatric Depression

Download Full-text

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

Expert Opinion on Pharmacotherapy ◽

10.1517/14656566.2014.935764 ◽

2014 ◽

Vol 15 (11) ◽

pp. 1501-1515 ◽

Cited By ~ 78

Author(s):

Nobuya Inagaki ◽

Kazuoki Kondo ◽

Toru Yoshinari ◽

Nahoko Takahashi ◽

Yutaka Susuta ◽

...

Keyword(s):

Type 2 Diabetes ◽

Japanese Patients ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo ◽

Diet And Exercise ◽

Phase Iii Study

Download Full-text

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

Case Medical Research ◽

10.31525/ct1-nct04033354 ◽

2019 ◽

Author(s):

Keyword(s):

Stage Iiib ◽

Phase Iii ◽

Line Treatment ◽

Efficacy And Safety ◽

First Line ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

First Line Treatment

Download Full-text

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Case Medical Research ◽

10.31525/ct1-nct04063163 ◽

2019 ◽

Author(s):

Keyword(s):

Lung Cancer ◽

Small Cell Lung Cancer ◽

Small Cell ◽

Phase Iii ◽

Efficacy And Safety ◽

Small Cell Lung ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study ◽

Extensive Stage

Download Full-text

Faculty Opinions recommendation of Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1103835.559964 ◽

2008 ◽

Author(s):

Deborah Kim

Keyword(s):

Fatty Acids ◽

Major Depressive Disorder ◽

Depressive Disorder ◽

Controlled Trial ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Major Depressive ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Faculty Opinions recommendation of Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717297963.792752819 ◽

2012 ◽

Author(s):

David Taylor ◽

Ethan Anderson

Keyword(s):

Heart Failure ◽

Fatty Acids ◽

Chronic Heart Failure ◽

Left Ventricular ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Systolic Left Ventricular Function ◽

Markers Of Inflammation ◽

Dose Dependent

Download Full-text

Faculty Opinions recommendation of Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717962498.793465528 ◽

2012 ◽

Author(s):

David Alpers

Keyword(s):

Peritoneal Carcinomatosis ◽

Bowel Obstruction ◽

Symptomatic Treatment ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Phase Iii Study

Download Full-text

Effects of exergame training combined with omega-3 fatty acids on the elderly brain: a randomized double-blind placebo-controlled trial

BMC Geriatrics ◽

10.1186/s12877-019-1084-4 ◽

2019 ◽

Vol 19 (1) ◽

Cited By ~ 3

Author(s):

Alexandra Schättin ◽

Corinne Baier ◽

Domenique Mai ◽

Verena Klamroth-Marganska ◽

Isabelle Herter-Aeberli ◽

...

Keyword(s):

Fatty Acids ◽

Controlled Trial ◽

The Elderly ◽

Omega 3 Fatty Acids ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia ― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―

Efficacy and safety of bilastine in Japanese patients with perennial allergic rhinitis: A multicenter, randomized, double-blind, placebo-controlled, parallel-group phase III study

A Randomized, Double-Blind, Placebo-Controlled, Phase III Study of the Short-Acting β1-Adrenergic Receptor Blocker Landiolol Hydrochloride for Coronary Computed Tomography Angiography in Japanese Patients with Suspected Ischemic Cardiac Disease

Omega-3 Fatty Acids as a Treatment for Pediatric Depression. A Phase III, 36 Weeks, Multi-Center, Double-Blind, Placebo-Controlled Randomized Superiority Study

Efficacy and safety of canagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled with diet and exercise: a 24-week, randomized, double-blind, placebo-controlled, Phase III study

A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC

A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

Faculty Opinions recommendation of Omega-3 fatty acids for major depressive disorder during pregnancy: results from a randomized, double-blind, placebo-controlled trial.

Faculty Opinions recommendation of Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study.

Faculty Opinions recommendation of Symptomatic treatment with lanreotide microparticles in inoperable bowel obstruction resulting from peritoneal carcinomatosis: a randomized, double-blind, placebo-controlled phase III study.

Effects of exergame training combined with omega-3 fatty acids on the elderly brain: a randomized double-blind placebo-controlled trial

Short-Term Efficacy (at 12 Weeks) and Long-Term Safety (up to 52 Weeks) of Omega-3 Free Fatty Acids (AZD0585) for the Treatment of Japanese Patients With Dyslipidemia　― A Randomized, Double-Blind, Placebo-Controlled, Phase III Study ―